68 related articles for article (PubMed ID: 9544674)
1. Capromab pendetide imaging of occult lymph node metastases.
Haseman MK
J Nucl Med; 1998 Apr; 39(4):653. PubMed ID: 9544674
[No Abstract] [Full Text] [Related]
2. Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients.
Polascik TJ; Manyak MJ; Haseman MK; Gurganus RT; Rogers B; Maguire RT; Partin AW
Cancer; 1999 Apr; 85(7):1586-92. PubMed ID: 10193950
[TBL] [Abstract][Full Text] [Related]
3. Possible false-positive metastatic prostate cancer on an In-111 capromab pendetide scan as a result of a pelvic kidney.
Valliappan S; Joyce JM; Myers DT
Clin Nucl Med; 1999 Dec; 24(12):984-5. PubMed ID: 10595486
[No Abstract] [Full Text] [Related]
4. Utility of capromab pendetide (ProstaScint) imaging in the management of prostate cancer.
Rosenthal SA; Haseman MK; Polascik TJ
Tech Urol; 2001 Mar; 7(1):27-37. PubMed ID: 11272670
[TBL] [Abstract][Full Text] [Related]
5. Immunoscintigraphy with indium-111-capromab pendetide: evaluation before definitive therapy in patients with prostate cancer.
Manyak MJ; Hinkle GH; Olsen JO; Chiaccherini RP; Partin AW; Piantadosi S; Burgers JK; Texter JH; Neal CE; Libertino JA; Wright GL; Maguire RT
Urology; 1999 Dec; 54(6):1058-63. PubMed ID: 10604708
[TBL] [Abstract][Full Text] [Related]
6. Dual-isotope protocol for indium-111 capromab pendetide monoclonal antibody imaging.
Kelty NL; Holder LE; Khan SH
J Nucl Med Technol; 1998 Sep; 26(3):174-7. PubMed ID: 9755436
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer abdominal metastases detected with indium-111 capromab pendetide.
Hinkle GH; Burgers JK; Olsen JO; Williams BS; Lamatrice RA; Barth RF; Rogers B; Maguire RT
J Nucl Med; 1998 Apr; 39(4):650-2. PubMed ID: 9544673
[TBL] [Abstract][Full Text] [Related]
8. Multicenter radioimmunoscintigraphic evaluation of patients with prostate carcinoma using indium-111 capromab pendetide.
Hinkle GH; Burgers JK; Neal CE; Texter JH; Kahn D; Williams RD; Maguire R; Rogers B; Olsen JO; Badalament RA
Cancer; 1998 Aug; 83(4):739-47. PubMed ID: 9708939
[TBL] [Abstract][Full Text] [Related]
9. Indium-111-capromab pendetide scans: an important test relevant to clinical decision making.
Sartor O; McLeod D
Urology; 2001 Mar; 57(3):399-401. PubMed ID: 11248605
[No Abstract] [Full Text] [Related]
10. Monoclonal antibody scan holds promise for prostate cancer staging.
Kotz D
J Nucl Med; 1996 Apr; 37(4):11N-12N, 15N. PubMed ID: 8691235
[No Abstract] [Full Text] [Related]
11. Gamma probe assisted ex vivo detection of small lymph node metastases following the administration of indium-111-labeled monoclonal antibodies to colorectal cancers.
Abdel Nabi H; Doerr RJ; Balu D; Rogan L; Farrell EL; Evans NH
J Nucl Med; 1993 Oct; 34(10):1818-22. PubMed ID: 8410303
[TBL] [Abstract][Full Text] [Related]
12. Indium-111 capromab pendetide (ProstaScint) images before and after salvage radiation therapy.
Welsh JS; Yanez MH; Chin BB; Howard SP
Clin Nucl Med; 1999 Dec; 24(12):983. PubMed ID: 10595485
[No Abstract] [Full Text] [Related]
13. Radioimmunoguided surgery using indium-111 capromab pendetide (PROSTASCINT) to diagnose supraclavicular metastasis from prostate cancer.
Anderson RS; Eifert B; Tartt S; King P
Urology; 2000 Oct; 56(4):669. PubMed ID: 11018634
[TBL] [Abstract][Full Text] [Related]
14. Capromab Pendetide immunoscintigraphy: connecting the dots for prostate cancer imaging.
Manyak MJ
Cancer Biother Radiopharm; 2000 Apr; 15(2):127-30. PubMed ID: 10803317
[No Abstract] [Full Text] [Related]
15. Single photon emission computerized tomography with capromab pendetide plus computerized tomography image set co-registration independently predicts biochemical failure.
Ellis RJ; Zhou EH; Fu P; Kaminsky DA; Sodee DB; Faulhaber PF; Bodner D; Resnick MI
J Urol; 2008 May; 179(5):1768-73; discussion 1773-4. PubMed ID: 18343445
[TBL] [Abstract][Full Text] [Related]
16. Capromab pendetide. A review of its use as an imaging agent in prostate cancer.
Lamb HM; Faulds D
Drugs Aging; 1998 Apr; 12(4):293-304. PubMed ID: 9571393
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of [90Y] yttrium-capromab pendetide in the treatment of men with prostate cancer recurrence following radical prostatectomy.
Kahn D; Austin JC; Maguire RT; Miller SJ; Gerstbrein J; Williams RD
Cancer Biother Radiopharm; 1999 Apr; 14(2):99-111. PubMed ID: 10850293
[TBL] [Abstract][Full Text] [Related]
18. Radioimaging of lymph node involvement in prostatic carcinoma.
Kontturi M; Lukkarinen O; Vihko P; Vihko R
Scand J Urol Nephrol Suppl; 1988; 110():113-7. PubMed ID: 3187398
[TBL] [Abstract][Full Text] [Related]
19. [Immunoscintigraphy of prostatic cancer].
Aliaev IuG; Vinarov AZ; Rapoport LM; Bezrukov EA; Butnaru DV
Urologiia; 2006; (4):67-9. PubMed ID: 17058687
[No Abstract] [Full Text] [Related]
20. Indium-111 capromab pendetide (ProstaScint) uptake in neurofibromatosis.
Khan A; Caride VJ
Urology; 2000 Jul; 56(1):154. PubMed ID: 10869655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
